Ulcerative colitis and colorectal cancer. A population-based study
- PMID: 2215606
- DOI: 10.1056/NEJM199011013231802
Ulcerative colitis and colorectal cancer. A population-based study
Abstract
Background: The risk of colorectal cancer is increased among patients with ulcerative colitis. The magnitude of this increase in risk and the effects of the length of follow-up, the extent of disease at diagnosis, and age at diagnosis vary substantially in different studies.
Methods: To provide accurate estimates of the risk of colorectal cancer among patients with ulcerative colitis, we studied a population-based cohort of 3117 patients given a diagnosis of ulcerative colitis from 1922 through 1983 who were followed up through 1984.
Results: Ninety-two cases of colorectal cancer occurred in 91 patients. As compared with the expected incidence, the incidence of colorectal cancer in the cohort was increased (standardized incidence ratio [ratio of observed to expected cases] = 5.7; 95 percent confidence interval, 4.6 to 7.0). Less extensive disease at diagnosis was associated with a lower risk; for patients with ulcerative proctitis, the standardized incidence ratio was 1.7 (95 percent confidence interval, 0.8 to 3.2); for those with left-sided colitis, 2.8 (95 percent confidence interval, 1.6 to 4.4); and for those with pancolitis (extensive colitis, or inflammation of the entire colon), 14.8 (95 percent confidence interval, 11.4 to 18.9). Age at diagnosis and the extent of disease at diagnosis were strong and independent risk factors for colorectal cancer. For each increase in age group at diagnosis (less than 15 years, 15 to 29 years, 30 to 39 years, 40 to 49 years, 50 to 59 years, and greater than or equal to 60 years), the relative risk of colorectal cancer, adjusted for the extent of disease at diagnosis, decreased by about half (adjusted standardized incidence ratio = 0.51; 95 percent confidence interval, 0.46 to 0.56). The absolute risk of colorectal cancer 35 years after diagnosis was 30 percent for patients with pancolitis at diagnosis and 40 percent for those given this diagnosis at less than 15 years of age.
Conclusions: Close surveillance and perhaps even prophylactic proctocolectomy should be recommended for patients given a diagnosis of pancolitis, especially those who are less than 15 years of age at diagnosis.
Similar articles
-
Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.Acta Chir Scand Suppl. 1989;552:1-45. Acta Chir Scand Suppl. 1989. PMID: 2800882
-
[Long-term prognosis of patients with ulcerative colitis].Ugeskr Laeger. 1993 Nov 15;155(46):3767-72. Ugeskr Laeger. 1993. PMID: 8256373 Danish.
-
Ulcerative colitis in Stockholm County--a study of epidemiology, prognosis, mortality and cancer risk with special reference to a surveillance program.Acta Chir Scand Suppl. 1986;534:1-60. Acta Chir Scand Suppl. 1986. PMID: 3472421
-
Chronic inflammatory bowel disease and cancer.Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70. Hepatogastroenterology. 2000. PMID: 10690586 Review.
-
Clinical course of ulcerative colitis.Dig Liver Dis. 2008 Jul;40 Suppl 2:S247-52. doi: 10.1016/S1590-8658(08)60533-2. Dig Liver Dis. 2008. PMID: 18598996 Review.
Cited by
-
Not just a clearance: Surgical risk in patients with cirrhosis.Clin Liver Dis (Hoboken). 2024 Mar 7;23(1):e0109. doi: 10.1097/CLD.0000000000000109. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38455234 Free PMC article. Review. No abstract available.
-
Distinct roles for interleukin-23 receptor signaling in regulatory T cells in sporadic and inflammation-associated carcinogenesis.Front Oncol. 2024 Feb 5;13:1276743. doi: 10.3389/fonc.2023.1276743. eCollection 2023. Front Oncol. 2024. PMID: 38375204 Free PMC article.
-
Aged oolong tea alleviates dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota and its metabolites.Food Chem X. 2023 Dec 29;21:101102. doi: 10.1016/j.fochx.2023.101102. eCollection 2024 Mar 30. Food Chem X. 2023. PMID: 38268839 Free PMC article.
-
What Is the Risk? Epidemiology and Evidence for Surveillance Regimens.Clin Colon Rectal Surg. 2023 Mar 8;37(1):13-17. doi: 10.1055/s-0043-1762558. eCollection 2024 Jan. Clin Colon Rectal Surg. 2023. PMID: 38188071 Free PMC article. Review.
-
High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival.Ups J Med Sci. 2024 Jan 2;28. doi: 10.48101/ujms.v128.10241. eCollection 2023. Ups J Med Sci. 2024. PMID: 38187473 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials